The National Institute of Allergy and Infectious Diseases has started a series of clinical trials on humans to examine a potential vaccine candidate NIAID hopes can help counter the Zika virus. NIAID started
Register to enjoy unlimited access to articles, interviews, and invaluable govcon content. You'll also receive our daily briefing straight to your inbox.